Para leer

  1. Medrano Albéniz, Juan
  2. Vispe Astola, A.
  3. García-Valdecasas Campelo, José
  4. Gamero Merino, Casimiro
Zeitschrift:
Revista de la Asociación Española de Neuropsiquiatría

ISSN: 0211-5735

Datum der Publikation: 2013

Ausgabe: 33

Nummer: 117

Seiten: 195-215

Art: Artikel

DIALNET GOOGLE SCHOLAR lock_openOpen Access editor

Andere Publikationen in: Revista de la Asociación Española de Neuropsiquiatría

Zusammenfassung

David Healy. Pharmageddon. (Juan Medrano). Jim Geekie, John Read. El sentido de la locura. (Amaia Vispe Astola, Jose G.-Valdecasas Campelo). Fernando Mansilla Izquierdo. Manual de riesgos psicosociales en el trabajo: teoría y práctica. (Casimiro Gamero Merino).

Bibliographische Referenzen

  • (1) Greene JA, Podolsky SH. Reform, regulation, and pharmaceuticals-the Kefauver-Harris Amendments at 50. N Engl J Med 2012; 367: 1481-3 [Accesible en: http://www.nejm.org/doi/pdf/10.1056/ NEJMp1210007]
  • (2) Coombes R. GlaxoSmithKline grants researchers access to clinical trial data. BMJ 2012; 345 doi: http://dx.doi. org/10.1136/bmj.e6909
  • (3) Godlee F. Clinical trial data for all drugs in current use. BMJ2012;345:e730 [Accesible en: http://www.bmj.com/ content/345/bmj.e7304.pdf%2Bhtml]
  • (4) Rathi V, Dzara K, Gross CP, Hrynaszkiewicz I, Joffe S, Krumholz HM, et al. Sharing of clinical trial data among trialists: a cross sectional survey. BMJ 2012;345:e7570 [Accesible en: http://www. bmj.com/content/345/bmj.e7570]
  • (5) Roehr B. GlaxoSmithKline is fined record $3bn in US.BMJ2012; 345 :e4568 [Accesible en: http://www.bmj.com/ content/345/bmj.e4568?ijkey=d7cb8321e1c ce2e79d2bccb98a738f8528d29401&keytyp e2=tf_ipsecsha&linkType=FULL&journalC ode=bmj&resid=345/jul03_2/e4568]
  • (6) Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 2012; 367: 124-34 [Abstract en http:// www.ncbi.nlm.nih.gov/pubmed/22738085].
  • (7) Wojcik J. Pharma giant threatens Danish scientist. Science Nordic, July 24, 2012 [Accesible en: http://sciencenordic. com/pharma-giant-threatens-danishscientist].
  • (8) Bellver JM, López A. Un nuevo enemigo para la industria farmacéutica. El Mundo, 14/09/2012 [Accesible en: http://www.elmundo.es/elmundosalud/2012/09/14/noticias/1347620518.html]
  • (9) Arie S. Ending the French love affair with drugs. BMJ 2012; 345: e6996 [Accesible en: http://www.bmj.com/ content/345/bmj.e6996]
  • (10) Skrabanek P. La muerte de la medicina con rostro humano. Madrid: Díaz de Santos, 1999
  • (11) Ludka FK, Zomkowski AD, Cunha MP, Dal-Cim T, Zeni AL, Rodrigues AL, et al. Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels. Eur Neuropsychopharmacol 2012 Jun 6. [Epub ahead of print] [Abstract en: http://www.ncbi.nlm.nih.gov/ pubmed/22682406]
  • (12) Redberg RF, Katz MH. Healthy men should not take statins. JAMA. 2012 Apr 11; 307:1491-2.
  • (13) Hartling L, Abou-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS. Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus SecondGeneration Medications: A Systematic Review and Meta-analysis. Ann Intern Med. 2012 Aug 14. doi: 10.7326/0003-4819-157- 7-201210020-00525. [Epub ahead of print] [Accesible en: http://annals.org/article. aspx?articleid=1309704]
Fuente de los datos: Dialnet